Dakota Community Bank & Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
2,081
-9
-0.4% -$1.35K 1.01% 27
2026
Q1
$319K Sell
2,090
-53
-2% -$8.12K 1.08% 29
2025
Q4
$295K Buy
2,143
+63
+3% +$8.25K 1.01% 32
2025
Q3
$267K Sell
2,080
-177
-8% -$21.6K 1.05% 33
2025
Q2
$273K Sell
2,257
-104
-4% -$11.7K 1.23% 27
2025
Q1
$263K Buy
2,361
+119
+5% +$12.7K 1.27% 29
2024
Q4
$218K Hold
2,242
1.04% 38
2024
Q3
$258K Sell
2,242
-25
-1% -$2.84K 1.3% 35
2024
Q2
$241K Buy
2,267
+58
+3% +$5.82K 1.3% 31
2024
Q1
$214K Buy
2,209
+95
+4% +$9.74K 1.16% 36
2023
Q4
$213K Buy
2,114
+45
+2% +$4.34K 1.2% 31
2023
Q3
$211K Sell
2,069
-24
-1% -$2.44K 1.34% 25
2023
Q2
$211K Sell
2,093
-132
-6% -$13.2K 1.25% 29
2023
Q1
$205K Sell
2,225
-105
-5% -$9.17K 1.27% 29
2022
Q4
$211K Sell
2,330
-145
-6% -$12.2K 1.2% 26
2022
Q3
$188K Buy
+2,475
New +$205K 1.3% 29

Other funds holding NVS

Dakota Community Bank & Trust's NVS Position: Q2 2026 in Review

Dakota Community Bank & Trust reduced its Novartis (NVS) stake by 0.43% in Q2 2026, selling an estimated $1.35K and leaving 2,081 shares worth $326K. The position accounts for 1.01% of the portfolio, ranked #27.

Dakota Community Bank & Trust first reported a position in NVS in Q3 2022 and has held it in 16 quarters since. 786 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Dakota Community Bank & Trust held 2,081 shares of Novartis worth $326K as of Q2 2026.
  • Dakota Community Bank & Trust sold 9 Novartis shares in Q2 2026, an estimated $1.35K.
  • Novartis made up 1.01% of Dakota Community Bank & Trust's portfolio in Q2 2026, its #27 holding.
  • Dakota Community Bank & Trust first reported a position in Novartis in Q3 2022 and has held it in 16 quarters since.
  • 786 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Dakota Community Bank & Trust's 13F filing for Q2 2026, filed 15 Jul 2026.